Results 241 to 250 of about 2,661,869 (346)

Comparative evaluation of cognitive behavioural therapy versus standard treatment in temporomandibular disorders: A systematic review

Journal of Oral Rehabilitation, Volume 52, Issue 4, Page 521-530, April 2025.
Graphical abstract of this systematic review. Abstract Background Temporomandibular disorders (TMDs) are musculoskeletal and neuromuscular conditions affecting the temporomandibular joint and associated structures. Cognitive‐behavioural therapy (CBT) has emerged as a potential intervention for TMDs, but its comparative effectiveness against standard ...
Sahana Shivakumar, Nishath Sayed Abdul, Bhuvan Jyoti, Veena Kalburgi, Marco Cicciù, Giuseppe Minervini   +5 more
wiley   +1 more source

Utilization of potentially inappropriate sedative-hypnotic and atypical antipsychotic medications among elderly individuals with insomnia and Alzheimer's disease. [PDF]

Sleep
Chekani F, Mirchandani K, Zaki S, Goswami S, Sharma M.   +4 more
europepmc   +1 more source

Chronic insomnia, REM sleep instability and emotional dysregulation: A pathway to anxiety and depression?

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary The world‐wide prevalence of insomnia disorder reaches up to 10% of the adult population. Women are more often afflicted than men, and insomnia disorder is a risk factor for somatic and mental illness, especially depression and anxiety disorders.
Dieter Riemann, Raphael J. Dressle, Fee Benz, Kai Spiegelhalder, Anna F. Johann, Christoph Nissen, Elisabeth Hertenstein, Chiara Baglioni, Laura Palagini, Lukas Krone, Michael L. Perlis, Katharina Domschke, Mathias Berger, Bernd Feige   +13 more
wiley   +1 more source

Substance use and risk of suicide among adults who sought mental health and addiction specialty services through a centralised intake process in Nova Scotia: a cross-sectional study. [PDF]

BMJ Open
Soboka M, Stewart SH, Tibbo P, Wang J.
europepmc   +1 more source

Paediatric sedation with intranasal dexmedetomidine: Protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Nissen KD, Moos CM, Wolf A, Strøm T.
europepmc   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng, Daniel Lorch, Nancy Hall, Margaret Moline   +3 more
wiley   +1 more source

What's old is new again: opioid and benzodiazepine actions on ventilation, a reminder of the importance of knowing one's drugs. [PDF]

Br J Anaesth
Meissner K, Kharasch ED.
europepmc   +1 more source

Orexin concentrations and diurnal variation in the cerebrospinal fluid of intensive care unit patients undergoing aortic surgery with spinal drainage. [PDF]

Neuropsychopharmacol Rep
Nishiyama S, Sekine A, Masuyama T, Nagatomo K, Kanbayashi T, Sanui M.   +5 more
europepmc   +1 more source

Sedative and Hypnotic Effects of Nuciferine: Enhancing Rodent Sleep via Serotonergic System Modulation [PDF]

Luo-Xuan Wang, Yumeng Liu, Yong-Fang Gu, Lü Li, Ren-Hong Qiu, Yankai Wang, Jin Kuk Yang, Ji Wang, Yang Zhang, Shuo Li, Qiong‐yin Fan, Rui Xue, Jing-Cao Li, You‐Zhi Zhang   +13 more
openalex   +1 more source

Correction: Time trends in self-reported depressive symptoms, prescription of antidepressants, sedatives and hypnotics and the emergence of social media among Norwegian adolescents. [PDF]

PLoS One
Lien L, Bonsaksen T, Stea TH, Kleppang AL, Steigen AM, Leonhardt M.   +5 more
europepmc   +1 more source